Literature DB >> 17858679

The Rationale of Whole Blood Therapy in Severe Burns : A Clinical Study.

E I Evans, I A Bigger.   

Abstract

Year:  1945        PMID: 17858679      PMCID: PMC1618324          DOI: 10.1097/00000658-194510000-00016

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  4 in total

1.  Studies on the Toxemia Syndrome After Burns II: Central Nervous System Changes as a Cause of Death.

Authors:  J Walker; H Shenkin
Journal:  Ann Surg       Date:  1945-03       Impact factor: 12.969

2.  A Study of the Interrelationship of Salt Solutions Serum and Defibrinated Blood in the Treatment of Severely Scalded, Anesthetized Dogs.

Authors:  C A Moyer; F A Coller; V Iob; H H Vaughan; D Marty
Journal:  Ann Surg       Date:  1944-09       Impact factor: 12.969

3.  PLASMA TRANSFUSION IN THE TREATMENT OF THE FLUID SHIFT IN SEVERE BURNS.

Authors:  J R Elkinton; W A Wolff; W E Lee
Journal:  Ann Surg       Date:  1940-07       Impact factor: 12.969

4.  Public Health Weekly Reports for DECEMBER 18, 1942.

Authors: 
Journal:  Public Health Rep       Date:  1942-12-18       Impact factor: 2.792

  4 in total
  5 in total

1.  The Importance of Whole Blood Transfusions in the Management of Severe Burns.

Authors:  J J McDonald; E F Cadman; J Scudder
Journal:  Ann Surg       Date:  1946-08       Impact factor: 12.969

2.  Fluid and electrolyte requirements in severe burns.

Authors:  E I EVANS; O J PURNELL; P W ROBINETT; A BATCHELOR; M MARTIN
Journal:  Ann Surg       Date:  1952-06       Impact factor: 12.969

3.  DISCUSSION: the treatment of burns in large numbers.

Authors: 
Journal:  Proc R Soc Med       Date:  1951-07

4.  Blood volumes in normal and burned dogs; a comparative study with radioactive phosphorus tagged red cells and T-1824 dye.

Authors:  A M SALZBERG; E I EVANS
Journal:  Ann Surg       Date:  1950-10       Impact factor: 12.969

5.  Treatment of burns.

Authors:  A B WALLACE
Journal:  Ann R Coll Surg Engl       Date:  1949-11       Impact factor: 1.891

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.